This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego
Register Now
Menu
Book Now

Gordon Marr, Ph.D.
Vice President, Analytical at Nitto Avecia

Agenda Sessions

  • Chairman’s Remarks: How to Define A Regulatory Strategy for Oligonucleotides in the Absence of Clear Guidelines

    , 8:25am
    View Session

  • Panel Discussion with Session Speakers

    , 11:45am
    View Session

Speakers at this event

Prev
Next
Jim Marshall
Director, Materials Management
Alnylam Pharmaceuticals, USA

See Gordon Speak

Register Now